Preclinical Development of Near-Infrared-Labeled CD38-Targeted Daratumumab for Optical Imaging of CD38 in Multiple Myeloma

Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma

Henk M. Lokhorst, Torben Plesner, Jacob P. Laubach et al. · New England Journal of Medicine · 2015 · 1.1K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Vitamin D Is Required for ILC3 Derived IL-22 and Protection From Citrobacter rodentium Infection

Yang‐Ding Lin, Juhi Arora, Kevin Diehl et al. · Frontiers in Immunology · 2019 · 599 citations · Full text

Life Sciences, Immunology, Nutritional Sciences +15

Fundamental limits of spatial resolution in PET

W.W. Moses · Nuclear Instruments and Methods in Physics Research Section A Accelerators Spectrometers Detectors and Associated Equipment · 2010 · 546 citations

Medicine, Nuclear Medicine, Biomedical Imaging +11

CD38 expression and complement inhibitors affect response and resistance to daratumumab therapy in myeloma

Inger S. Nijhof, Tineke Casneuf, Jeroen van Velzen et al. · Blood · 2016 · 380 citations · Full text

Life Sciences, Immunology, Oncology +13

Upregulation of CD38 expression on multiple myeloma cells by all-trans retinoic acid improves the efficacy of daratumumab

Inger S. Nijhof, Richard W.J. Groen, H M Lokhorst et al. · Leukemia · 2015 · 266 citations · Full text

Medicine, Immunology, Pharmacology +17